These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5496091)

  • 21. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
    Polna I; Naruszewicz-Lesiuk D; Pilecka T
    Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
    Topciu V; Moldovan E; Csaky N; Băcilă E
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
    [No Abstract]   [Full Text] [Related]  

  • 26. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of measles vaccines in Japan.
    Ueda S
    Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Follow-up studies 5 and a half years after measles vaccination in Basel].
    Ritzel G; Just M
    Schweiz Med Wochenschr; 1972 Mar; 102(10):342. PubMed ID: 5034970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 31. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against measles: clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee.
    Br Med J; 1968 May; 2(5603):449-52. PubMed ID: 5648287
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J
    CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles vaccination of macaques by dry powder inhalation.
    de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
    Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 40. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.